Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
ARC Industry Laureate Post Doctoral Research Associate in Effecting Solutions for Risk to Remote Ind
more via our website and stay connected with our stories and people on LinkedIn . Your next career opportunity As a Post Doctoral Research Associate in the ARC Industry Laureate Fellowship program
-
Full time research position, initial two-year fixed term with possibility of extension Opportunity to lead a research program in small molecule drug discovery Located at the Chemistry Building (F11
-
Full time research position, initial two-year fixed term with possibility of extension Opportunity to lead a research program in peptide drug discovery Located at the Chemistry Building (F11
-
double-edged sword” funded by the Australian Research Council. The project will use state-of-the art computer models that incorporate the latest frameworks on soil organic matter interacting with plant
-
Employee Assistance Program for staff and their immediate family UQ Study for Staff On campus childcare options Affordable parking (from just $6.15 a day) Salary packaging options About You Diploma in
-
or a related field (e.g. statistics, risk management, economics, quantitative finance) Proven research experience in aged care, longevity, or health risk Strong skills in data analysis and computational
-
languages (C, C++, C#, Python, Matlab), experience with machine learning in robotics or computer vision, a desire to advance resilient, introspective processing architectures in robotics, a desire to work
-
are invited to join an exciting research program within the Molecular Biomarkers and Translational Genomics Laboratory led by Sarah-Jane Dawson at the Peter MacCallum Cancer Centre (www.thedawsonlab.com). The
-
fundamental research and the pharmaceutical and biotechnology industries. The research program is co-funded by the Australian Research Council and the Sydney- and US-based biotech company INSAMO and the
-
responsible for the conduct of experiments and analysis of data related to a program developing novel therapeutic approaches for ocular and/or vascular disease. The incumbent will be a key contributor in this